{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:48:50Z","timestamp":1789728530460,"version":"4.0.1"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2,1]]},"DOI":"10.1093\/cid\/cir884","type":"journal-article","created":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T18:56:48Z","timestamp":1326481008000},"page":"S67-S72","source":"Crossref","is-referenced-by-count":60,"title":["How Does Antifungal Pharmacology Differ for Mucormycosis Versus Aspergillosis?"],"prefix":"10.1093","volume":"54","author":[{"given":"Russell E.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Spellberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Roilides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Kontoyiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,2,1]]},"reference":[{"key":"key\n\t\t\t\t20171013233019_bib1","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3324\/haematol.2009.012054","article-title":"Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study","volume":"95","author":"Pagano","year":"2010","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20171013233019_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013233019_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/510592","article-title":"Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality","volume":"44","author":"Upton","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013233019_bib4","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3201\/eid1509.090334","article-title":"Increasing incidence of zygomycosis (mucormycosis), France, 1997\u20132006","volume":"15","author":"Bitar","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20171013233019_bib5"},{"key":"key\n\t\t\t\t20171013233019_bib6","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013233019_bib7","doi-asserted-by":"crossref","first-page":"e1000549","DOI":"10.1371\/journal.pgen.1000549","article-title":"Genomic analysis of the basal lineage fungus Rhizopus oryzae reveals a whole-genome duplication","volume":"5","author":"Ma","year":"2009","journal-title":"PLoS Genet"},{"key":"key\n\t\t\t\t20171013233019_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/mmy.40.1.61.71","article-title":"Molecular cloning of an extracellular aspartic proteinase from Rhizopus microsporus and evidence for its expression during infection","volume":"40","author":"Schoen","year":"2002","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20171013233019_bib9","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/13693780600936399","article-title":"Characterization of an extracellular subtilisin protease of Rhizopus microsporus and evidence for its expression during invasive rhinoorbital mycosis","volume":"44","author":"Spreer","year":"2006","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20171013233019_bib10","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2337\/diacare.31.12.1109","article-title":"A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability","volume":"31","author":"Artis","year":"1982","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20171013233019_bib11","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1128\/IAI.41.3.1269-1278.1983","article-title":"Fungistatic mechanism of human transferrin for Rhizopus oryzae and Trichophyton mentagrophytes: alternative to simple iron deprivation","volume":"41","author":"Artis","year":"1983","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20171013233019_bib12","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1086\/500212","article-title":"Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases","volume":"42","author":"van Burik","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013233019_bib13","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1128\/EC.00151-07","article-title":"Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates","volume":"6","author":"Coste","year":"2007","journal-title":"Eukaryot Cell"},{"key":"key\n\t\t\t\t20171013233019_bib14","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2958.2008.06176.x","article-title":"An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1","volume":"68","author":"Selmecki","year":"2008","journal-title":"Mol Microbiol"},{"key":"key\n\t\t\t\t20171013233019_bib15","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1128\/AAC.00163-06","article-title":"In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts","volume":"50","author":"Sabatelli","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib16","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/AAC.46.5.1581-1582.2002","article-title":"In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B and fluconazole against 37 clinical isolates of zygomycetes","volume":"46","author":"Sun","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/dkg020","article-title":"In vitro susceptibilities of zygomycetes to conventional and new antifungals","volume":"51","author":"Dannaoui","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib18","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1128\/AAC.01488-07","article-title":"Comparison of lipid amphotericin B preparations in treating murine zygomycosis","volume":"52","author":"Ibrahim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib19","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013233019_bib20","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/605445","article-title":"Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome","volume":"200","author":"Singh","year":"2009","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013233019_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/AAC.00705-08","article-title":"Antifungal therapeutic drug monitoring: established and emerging indications","volume":"53","author":"Andes","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/jac\/dkn224","article-title":"Does pre-exposure of Aspergillus fumigatus to voriconazole or posaconazole in vitro affect its virulence and the in vivo activity of subsequent posaconazole or voriconazole, respectively? A study in a fly model of aspergillosis","volume":"62","author":"Lamaris","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib23","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00006454-199908000-00010","article-title":"Amphotericin B lipid complex in pediatric patients with invasive fungal infections","volume":"18","author":"Walsh","year":"1999","journal-title":"Pediat Inf Dis J"},{"key":"key\n\t\t\t\t20171013233019_bib24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013233019_bib25","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013233019_bib26","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1128\/AAC.01449-06","article-title":"Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis","volume":"51","author":"Lewis","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib27","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/AAC.01222-09","article-title":"Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis","volume":"54","author":"Lewis","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib28","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1128\/AAC.00662-08","article-title":"Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing","volume":"52","author":"Lass-Florl","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib29","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1128\/AAC.00241-06","article-title":"Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations","volume":"50","author":"Groll","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib30","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1086\/315643","article-title":"Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system","volume":"182","author":"Groll","year":"2000","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013233019_bib31","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1128\/AAC.44.8.2068-2076.2000","article-title":"Dose-dependent pharmacokinetics of amphotericin B lipid complex in rabbits","volume":"44","author":"Walsh","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib32","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1128\/AAC.42.9.2391","article-title":"Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients","volume":"42","author":"Walsh","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib33","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/AAC.45.12.3487-3496.2001","article-title":"Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study","volume":"45","author":"Walsh","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib34","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1128\/AAC.49.2.830-832.2005","article-title":"Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice","volume":"49","author":"Spellberg","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013233019_bib36","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1128\/AAC.01065-06","article-title":"Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis","volume":"50","author":"Reed","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib37","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1128\/AAC.00361-09","article-title":"Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis","volume":"53","author":"Spellberg","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib38"},{"key":"key\n\t\t\t\t20171013233019_bib39","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/AAC.49.2.721-727.2005","article-title":"Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis","volume":"49","author":"Ibrahim","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib40","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.01458-07","article-title":"Combination echinocandin-polyene treatment of murine mucormycosis","volume":"52","author":"Ibrahim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib41"},{"key":"key\n\t\t\t\t20171013233019_bib42","doi-asserted-by":"crossref","first-page":"e1000040","DOI":"10.1371\/journal.ppat.1000040","article-title":"Stimulation of chitin synthesis rescues Candida albicans from echinocandins","volume":"4","author":"Walker","year":"2008","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20171013233019_bib43","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1128\/AAC.00854-09","article-title":"Transcriptional regulation of chitin synthases by calcineurin controls paradoxical growth of Aspergillus fumigatus in response to caspofungin","volume":"54","author":"Fortwendel","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1086\/589290","article-title":"Immunocompromised hosts: immunopharmacology of modern antifungals","volume":"47","author":"Ben-Ami","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013233019_bib45","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1086\/589305","article-title":"Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae","volume":"198","author":"Lamaris","year":"2008","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013233019_bib46","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.4049\/jimmunol.0804250","article-title":"Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus","volume":"182","author":"Werner","year":"2009","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20171013233019_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1997.15.1.139","article-title":"Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery","volume":"15","author":"Caillot","year":"1997","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20171013233019_bib48","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/509917","article-title":"Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign","volume":"44","author":"Greene","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013233019_bib49","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s10156-004-0315-5","article-title":"Pathophysiology of pulmonary aspergillosis","volume":"10","author":"Shibuya","year":"2004","journal-title":"J Infect Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib50","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1164\/ajrccm.152.3.7663787","article-title":"Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression","volume":"152","author":"Berenguer","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20171013233019_bib51","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jinf.2009.06.002","article-title":"A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response","volume":"59","author":"Ben-Ami","year":"2009","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20171013233019_bib52","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1086\/521245","article-title":"The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients","volume":"45","author":"Lass-Florl","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013233019_bib53"},{"key":"key\n\t\t\t\t20171013233019_bib54","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1086\/599105","article-title":"Recent advances in the management of mucormycosis: from bench to bedside","volume":"48","author":"Spellberg","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013233019_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.6.1.1","article-title":"Compounds active against cell walls of medically important fungi","volume":"6","author":"Hector","year":"1993","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20171013233019_bib56","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1128\/AAC.45.12.3310-3321.2001","article-title":"Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus","volume":"45","author":"Chiou","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib57","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1128\/AAC.00184-09","article-title":"In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes","volume":"53","author":"Dannaoui","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013233019_bib58","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/0006-2952(94)90314-X","article-title":"Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus","volume":"47","author":"de Locht","year":"1994","journal-title":"Biochem Pharmacol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/54\/suppl_1\/S67\/20911134\/cir884.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T18:36:51Z","timestamp":1593542211000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/54\/suppl_1\/S67\/285825\/How-Does-Antifungal-Pharmacology-Differ-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,1]]},"references-count":58,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2012,2,1]]},"published-print":{"date-parts":[[2012,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cir884","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2012,2,1]]},"published":{"date-parts":[[2012,2,1]]}}}